@ARTICLE{
author={Fung S,Kwan Peter,Horban A,Pelemis Mijomir R,Husa P,Hann HW,Flaherty John F,Massetto Benedetto,Dinh Phillip,Custodio J,Subramanian GM,Fabri Milotka J,Gane E},
year={2013},
title={Tenofovir Df (Tdf) Is Safe and Well Tolerated in Chronic Hepatitis B (Chb) Patients with Pre-Existing Mild Renal Impairment},
journal={JOURNAL OF HEPATOLOGY},
volume={58},
number={},
pages={S301-S302},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Mocroft Amanda,Phillips A,Gatell Jose,Horban A,Ledergerber B,Zilmer Kai,Jevtovic Djordje Lj,Maltez Fernando,Kirk O,Lundgren Jens D},
year={2012},
title={CD4 count and viral load specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use},
journal={JOURNAL OF THE INTERNATIONAL AIDS SOCIETY},
volume={15},
number={},
pages={17-19},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Ferenci Peter,Marcellin Patrick,Puoti M,Orlandini A,Bozic M,Schuller J,Mulkay JP,Tice A,Pruthi J,Craxi A,Messinger D,Tatsch F,Horban A},
year={2011},
title={Fib-4 Score Is a Stronger Predictor of Virological Response Than Liver Biopsy (Metavir) in Hepatitis C Genotype 1 Patients: Interim Data From the Prophesys Trial},
journal={JOURNAL OF HEPATOLOGY},
volume={54},
number={},
pages={S170-S170},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Schneider J,Halota W,Delic Dragan S,Nesic Zorica I,Prokopowicz D,Flisiak R,Kuydowicz J,Jablkowski M,Cianciara J,Mach T,Modrzewska R,Fabri Miklos,Tomic Dragan V,Horban A,Krycka W,Cripps M},
year={2006},
title={A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B: a phase IIa clinical trial},
journal={JOURNAL OF CLINICAL VIROLOGY},
volume={36},
number={},
pages={S30-S30},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Schneider J,Halota W,Delic Dragan S,Nesic Zorica I,Prokopowicz D,Flisiak R,Kuydowicz J,Jablkowski M,Cianciara J,Mach T,Modrzewska R,Fabri Miklos,Tomic Dragan V,Horban A,Krycka W,Cripps M},
year={2006},
title={A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg plus chronic hepatitis B: A phase IIa clinical trial},
journal={JOURNAL OF HEPATOLOGY},
volume={44},
number={},
pages={S277-S278},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={van de Vijver David A,Wensing Annemarie MJ,Angarano G,Asjo Birgitta,Balotta Claudia,Boeri E,Camacho Ricardo J,Chaix ML,Costagliola D,de Luca Andrea,Derdelinckx I,Grossman Z,Hamouda Osamah,Hatzakis A,Hemmer R,Hoepelman A,Horban A,Korn Klaus,Kucherer Claudia,Leitner T,Loveday C,MacRae E,Maljkovic Irina,de Mendoza C,Meyer L,Nielsen Claus,de Coul ELMO,Ormaasen V,Paraskevis Dimitris,Perrin L,Puchhammer-Stockl Elisabeth,Ruiz Lidia,Salminen Mika,Schmit Jean-Claude,Schneider F,Schuurman Rob,Soriano V,Stanczak G,Stanojevic Maja P,Vandamme Anne-Mieke,Van Laethem K,Violin M,Wilbe K,Yerly S,Zazzi M,Boucher Charles AB},
year={2006},
title={The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes},
journal={JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES},
volume={41},
number={3},
pages={352-360},
document_type={Article},
} 

@ARTICLE{
author={Halota W,Delic Dragan S,Nesic Zorica I,Prokopowicz D,Flisiak R,Kuydowicz J,Jablkowski I,Cianciara J,Mach T,Modrzewska R,Fabri Miklos,Tomic Dragan V,Horban A,Krycka W,Schneider J,Pearce G},
year={2005},
title={A novel primeboost immunotherapy induces high levels of HBeAg loss after 14 weeks in patients with HBeAg plus chronic hepatitis B: A phase IIA clinical trial},
journal={HEPATOLOGY},
volume={42},
number={4},
pages={269A-270A},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={de Vijver DV,Wensing Annemarie MJ,Angarano G,Asjo Birgitta,Balotta Claudia,Boeri E,Camacho Ricardo J,Chaix ML,Costagliola D,de Coul ELMO,de Luca Andrea,Maljkovic Irina,de Mendoza C,Derdelinckx I,Grossman Z,Hamouda Osamah,Hatzakis A,Hoepelman IM,Hemmer R,Horban A,Korn Klaus,Kucherer Claudia,Leitner T,Loveday C,MacRae E,Meyer L,Nielsen Claus,Ormaasen V,Perrin L,Paraskevis Dimitris,Puchhammer-Stockl Elisabeth,Ruiz Lidia,Salminen Mika,Schmit Jean-Claude,Schneider F,Schuurman Rob,Soriano V,Stanczak G,Stanojevic Maja P,Vandamme Anne-Mieke,Van Laethem K,Violin M,Wilbe K,Yerly S,Zazzi M,Boucher Charles AB},
year={2005},
title={Differences in the frequency of minor substitutions between HIV-1 subtypes and their potential impact on the genetic barrier for resistance to protease inhibitors},
journal={ANTIVIRAL THERAPY},
volume={10},
number={},
pages={S145-S145},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={van de Vijver David A,Wensing Annemarie MJ,Asjo Birgitta,Bruckova M,Jorgensen LB,Horban A,Linka M,Lazanas M,Loveday C,MacRae E,Nielsen Claus,Paraskevis Dimitris,Poljak Mario,Puchhammer-Stockl Elisabeth,Ruiz Lidia,Schmit Jean-Claude,Stanczak G,Stanojevic Maja P,Vandamme Anne-Mieke,Vercauteren Jurgen,Boucher Charles AB},
year={2005},
title={Selective transmission of drug resistance mutations},
journal={ANTIVIRAL THERAPY},
volume={10},
number={},
pages={S126-S126},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={van de Vijver David A,Wensing Annemarie MJ,Angarano G,Asjo Birgitta,Balotta Claudia,Boeri E,Camacho Ricardo J,Chaix ML,Costagliola D,de Coul ELMO,de Luca Andrea,Maljkovic Irina,de Mendoza C,Derdelinckx I,Grossman Z,Hamouda Osamah,Hatzakis A,Hoepelman IM,Hemmer R,Horban A,Korn Klaus,Kucherer Claudia,Leitner T,Loveday C,MacRae E,Meyer L,Nielsen Claus,Ormaasen V,Perrin L,Paraskevis Dimitris,Puchhammer-Stockl Elisabeth,Ruiz Lidia,Salminen Mika,Schmit Jean-Claude,Schneider F,Schuurman Rob,Soriano V,Stanczak G,Stanojevic Maja P,Vandamme Anne-Mieke,Van Laethem K,Violin M,Wilbe K,Yerly S,Zazzi M,Boucher Charles AB},
year={2005},
title={Differences in the frequency of minor substitutions between HIV-1 subtypes and their potential impact on the genetic barrier for resistance to protease inhibitors},
journal={ANTIVIRAL THERAPY},
volume={10},
number={4},
pages={S145-S145},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={van de Vijver David A,Wensing Annemarie MJ,Asjo Birgitta,Bruckova M,Jorgensen LB,Horban A,Linka M,Lazanas M,Loveday C,MacRae E,Nielsen Claus,Paraskevis Dimitris,Poljak Mario,Puchhammer-Stockl Elisabeth,Ruiz Lidia,Schmit Jean-Claude,Stanczak G,Stanojevic Maja P,Vandamme Anne-Mieke,Vercauteren Jurgen,Boucher Charles AB},
year={2005},
title={Selective transmission of drug resistance mutations},
journal={ANTIVIRAL THERAPY},
volume={10},
number={4},
pages={S126-S126},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Wensing Annemarie MJ,van de Vijver David A,Angarano G,Asjo Birgitta,Balotta Claudia,Boeri E,Camacho Ricardo J,Chaix ML,Costagliola D,de Luca Andrea,Derdelinckx I,Grossman Z,Hamouda Osamah,Hatzakis A,Hemmer R,Hoepelman A,Horban A,Korn Klaus,Kucherer Claudia,Leitner T,Loveday C,MacRae E,Maljkovic Irina,de Mendoza C,Meyer L,Nielsen Claus,de Coul ELMO,Ormaasen V,Paraskevis Dimitris,Perrin L,Puchhammer-Stockl Elisabeth,Ruiz Lidia,Salminen Mika,Schmit Jean-Claude,Schneider F,Schuurman Rob,Soriano V,Stanczak G,Stanojevic Maja P,Vandamme Anne-Mieke,Van Laethem K,Violin M,Wilbe K,Yerly S,Zazzi M,Boucher Charles AB},
year={2005},
title={Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management},
journal={JOURNAL OF INFECTIOUS DISEASES},
volume={192},
number={6},
pages={958-966},
document_type={Article},
} 

@ARTICLE{
author={van de Vijver David A,Wensing Annemarie MJ,Angarano G,Asjo Birgitta,Balotta Claudia,Boeri E,Camacho Ricardo J,Chaix MI,Costagliola D,de Coul ELMO,de Luca Andrea,Maljkovic Irina,de Mendoza C,Derdelinckx I,Grossman Z,Hamouda Osamah,Hatzakis A,Grossman Z,Hamouda Osamah,Hatzakis A,Hoepelman IM,Hemmer R,Horban A,Korn Klaus,Kucherer Claudia,Leitner T,Loveday C,MacRae E,Meyer L,Nielsen Claus,Ormaasen V,Perrin L,Paraskevis Dimitris,Puchhammer-Stockl Elisabeth,Ruiz Lidia,Salminen Mika,Schmit Jean-Claude,Schneider F,Schuurman Rob,Soriano V,Stanczak G,Stanojevic Maja P,Vandamme Anne-Mieke,Van Laethem K,Violin M,Wilbe K,Yerly S,Zazzi M,Boucher Charles AB},
year={2004},
title={The calculated genetic barrier for drug resistance mutations in six different non-B subtypes and two CRFs in a large European dataset is largely similar to subtype B},
journal={ANTIVIRAL THERAPY},
volume={9},
number={4},
pages={U74-U75},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Wensing Annemarie MJ,van de Vijver David A,Asjo Birgitta,Balotta Claudia,Camacho Ricardo J,De Mendoza C,Deroo S,Derdelinckx I,Grossman Z,Hamouda Osamah,Hatzakis A,Hoepelman A,Horban A,Korn Klaus,Kucherer Claudia,Nielsen Claus,Ormaasen V,Perrin L,Paraskevis Dimitris,Puchhammer-Stockl Elisabeth,Roman F,Salminen Mika,Schmit Jean-Claude,Soriano V,Stanczak G,Stanojevic Maja P,Vandamme Anne-Mieke,Van Laethem K,Violin M,Yerly S,Zazzi M,Boucher Charles AB},
year={2003},
title={Prevalence of transmitted drug resistance in Europe is largely influenced by the presence of non-B sequences: analysis of 1400 patients from 16 countries: the CATCH-Study},
journal={ANTIVIRAL THERAPY},
volume={8},
number={3},
pages={U114-U115},
document_type={Meeting Abstract},
}